Core proposition

Chronic senescence in intestinal stromal cells doesn't merely disrupt Wnt/β‑catenin gradients; it actively rewires them into a self‑reinforcing loop where sPtK7 secretion engages Fzd7, triggers non‑canonical Wnt/Ca²⁺ signaling, activates YAP, and YAP‑dependent transcription further amplifies sPtK7 expression. This creates a feed‑forward circuit that locks the niche in a low‑β‑catenin, high‑YAP state, promoting stromal activation and collagen deposition while suppressing ISC differentiation.

Why this matters

If true, senolytics that remove these stromal senescent cells would not only restore canonical Wnt signaling but also break the sPtK7‑YAP feedback loop, yielding a dual benefit: improved ISC function and reduced fibrosis. Conversely, in young tissue where senescent cells are transient and lack sustained sPtK7 up‑regulation, the loop does not engage, explaining why senolytic treatment does not impair regeneration.

Testable predictions

1. Molecular – In aged mouse intestinal crypts, stromal cells will show co‑localization of sPtK7, phosphorylated Fzd7, and nuclear YAP, whereas young crypts will display only transient, low‑level signals.
2. Genetic – Stromal‑specific knockout of sPtK7 or Fzd7 in aged mice will prevent YAP nuclear translocation, restore β‑catenin gradient (measured by Axin2‑LacZ reporter), and increase ISC proliferation without affecting wound‑healing responses.
3. Pharmacologic – Treatment with a YAP‑TEAD inhibitor (e.g., verteporfin) in aged mice will phenocopy senolytic effects: reduced collagen deposition, elevated crypt depth, and improved organoid formation, even without clearing senescent cells.
4. Temporal – Inducing acute senescence (e.g., via p16‑3MR transgene and short‑term ganciclovir) will not sustain sPtK7‑YAP activation beyond 48 h; only chronic (>2 weeks) senescence will establish the feed‑forward loop.
5. Human relevance – Fibrotic colonic biopsies from elderly patients will exhibit higher sPtK7 and nuclear YAP staining compared with noninflamed controls, and these markers will correlate inversely with β‑catenin‑target gene expression.

Falsifiability

If any of the following observations hold, the hypothesis is weakened:

• Stromal sPtK7 levels remain unchanged with age, yet Wnt gradient disruption persists.
• YAP inhibition fails to rescue ISC function or fibrosis despite senescent cell clearance.
• Transient senescence models produce lasting sPtK7‑YAP activation comparable to chronic conditions.

Mechanistic insight beyond the seed

The seed idea framed senescent cells as passive witnesses. Here we propose they become active signal processors that convert a diffusible Wnt modulator (sPtK7) into a intracellular transduction hub (Fzd7‑YAP) that rewires niche signaling. This shifts the narrative from simple loss of a chaperone to gain of a maladaptive signaling circuit that can be targeted upstream (sPtK7/Fzd7) or downstream (YAP) to rejuvenate the niche without broadly eliminating senescent cells, offering a finer‑grained therapeutic strategy.

Experimental outline

• Model: Aged (20‑month) C57BL/6 mice; young (3‑month) controls.
• Readouts: Immunofluorescence for sPtK7, p‑Fzd7, nuclear YAP, Axin2‑LacZ; qPCR for collagen‑1, Acta2; organoid formation assay; BrdU incorporation in Lgr5+ ISCs.
• Interventions: (i) Stromal‑specific Cre‑Ert2 driving sPtK7 or Fzd7 floxed alleles; (ii) Verteporfin treatment; (iii) Navitoclax senolytic as comparator.

By directly testing whether the sPtK7‑Fzd7‑YAP axis sustains the pathological Wnt state, this hypothesis moves beyond correlative senescence markers to a mechanistic node whose disruption predicts both functional rescue and fibrosis attenuation.